LOGIN  |  REGISTER
Recursion
Cue Biopharma

DBV Technologies: Information regarding the total number of voting rights and  total number of shares of the Company as of April 30, 2025

May 06, 2025 | Last Trade: US$10.83 0.16 -1.46

Information regarding the total number of voting rights and  total number of shares of the Company as of April 30, 2025

(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Market : NYSE Euronext Paris
ISIN Code: FR 0010417345


 

Date


 
Total number of shares Total number of voting rights
04/30/2025


 
136,948,872


 

 

Total gross of voting rights: 136,948,872


 

 

Total net* of voting rights: 136,762,549


 

* Net total = total number of voting rights attached to shares – shares without voting rights

Assertio

Stock Quote

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page